Pharmaceutical Research and Manufacturers of America
Pharmaceutical Research and Manufacturers of America (PhRMA) is a Washington, DC–based organization that files as a public charity. Its stated mission is to advocate for public policies that encourage biopharmaceutical research companies to discover new medicines for patients. Its 2024 filing reports 461 grants totaling $41.4 million.
Pharmaceutical Research and Manufacturers of America at a glance
In short: Pharmaceutical Research and Manufacturers of America gave $41.4M across 461 grants in 2024 (avg $90K), mostly in District of Columbia. 37% of 2024 grantees were new. Source: 2024 IRS Form 990.
- Annual giving (2024)
- $41,411,554
- +32.1% vs 2023
- Grants made (2024)
- 461
- +24.6% vs 2023
- Average grant
- $89,830
- +6.1% vs 2023
- Median grant
- $20,000
- Total assets
- $349,012,370
- -12.5% vs 2023
- New grantees (estimate)
- 37% first-time grantees (168 of 460, 2024)
- Primary geography
- District of Columbia (52% of itemized 2024 grant dollars)
- Latest 990 filing
- Form 990, 2024 View filing
Data from IRS Form 990, 2024; updated October 2026. New grantees are estimated by matching recipient names across years (methodology).
How to apply to Pharmaceutical Research and Manufacturers of America
- Contact
Mailing address: 670 Maine Avenue Sw 1000, Washington, DC 20024-3556
Phone: (202) 835-3400
Website: https://phrma.org
Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.
Who Pharmaceutical Research and Manufacturers of America funds
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
The largest 2024 recipient was We Work for Health ($6.8M). Together the top 10 received $20.7M.
Grant Size Distribution
2,205 grants across all recorded years
The most common grant size was under $50K: 1,643 grants of 2,205 (75%).
Geographic Focus
Where this funder awards grants
PhRMA’s filing describes work with governmental and regulatory bodies in the United States and throughout the world. In 2024, the largest shares of grant dollars went to recipients in DC (52%), Connecticut (12%), California (7%), Virginia (6%), and New York (3%).
Grant Distribution by State
Share of 2024 grant dollars across all 461 itemized grants.
States
Cities
Is Pharmaceutical Research and Manufacturers of America open to new grantees?
37%
first-time grantees, 2024
In 2024, 168 of 460 grantees (37%) were first-time recipients. First grants averaged $27K; repeat grants $126K. How we count
Medians: $12K first-time, $25K repeat.
- 51% of 2024 grantees were also funded in 2023. Method
- Giving held roughly steady from 2021 to 2024 (−11%). Method
Estimate from itemized grant lists in IRS Form 990 filings (2020–2024). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2024, annual grant giving ranged from $31.3M (2023) to $50.9M (2020). In 2024 it made 461 grants totaling $41.4M.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| We Work for Health Washington, DC | General Contribution | $6,827,095 |
| Yale University New Haven, CT | General Contribution | $5,000,000 |
| American Action Network Inc Washington, DC | General Contribution | $4,000,000 |
| National Consumers League Inc Washington, DC | General Contribution | $875,000 |
| National Alliance of Healthcare Purchaser Coalition Washington, DC | General Contribution | $850,000 |
| Phrma Independent Expenditure Committee Sacramento, CA | Political Contribution | $842,096 |
| Campaign to Protect Patient Health Bettendorf, IA | General Contribution | $660,000 |
| Council for Affordable Health Coverage Washington, DC | General Contribution | $615,000 |
| Republican State Leadership Committee Washington, DC | Political Contribution | $550,000 |
| Information Technology & Innovation Foundation Washington, DC | General Contribution | $515,000 |
Ready to take the next step with Pharmaceutical Research and Manufacturers of America?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2024 | $349,012,370 | $521,348,217 | $578,265,057 | $41,411,554 | 461 | $11,851,925 |
| 2023 | $398,950,677 | $483,040,082 | $426,549,040 | $31,336,856 | 370 | $14,913,289 |
| 2022 | $286,234,000 | $568,384,699 | $574,376,853 | $50,895,359 | 433 | $2,760,411 |
| 2021 | $284,877,801 | $609,259,357 | $588,810,520 | $46,505,902 | 469 | $3,318,295 |
| 2020 | $213,146,031 | $573,617,938 | $550,191,718 | $50,937,548 | 472 | $5,146,500 |
Research compiled by Grantable AI from public sources. Last updated October 2026.
Mission & Focus Areas
PhRMA’s mission is to conduct effective advocacy for public policies that encourage the discovery of important new medicines for patients by biopharmaceutical research companies. Its filing describes advocacy for broad patient access to safe and effective medicines, strong intellectual property incentives, transparent and efficient regulation, and the free flow of information to patients. It also describes providing a forum for member companies to discuss health care issues and develop policy positions, and disseminating information about the industry.
The 2024 grants show support for a range of organizations. Their stated missions include advancing public policies to improve patients’ health and well-being (We Work for Health), promoting center-right policies (American Action Network), protecting consumers and workers (National Consumers League), and advancing safe, efficient, high-quality health care (National Alliance of Healthcare Purchaser Coalitions). Other recipients describe missions focused on reducing health care costs, accelerating innovation, representing people with chronic diseases and disabilities, and improving care and research for people with autoimmune disease.
Grantmaking
In 2024, PhRMA reported 461 grants totaling $41,411,554. Grant amounts ranged from $5,250 to $6,827,095, with a median of $20,000. The largest grants included $6,827,095 to We Work for Health, $5,000,000 to Yale University, and $4,000,000 to American Action Network. Other notable awards included $875,000 to National Consumers League, $850,000 to National Alliance of Healthcare Purchaser Coalition, and $615,000 to Council for Affordable Health Coverage. The filing also lists political contributions, including $842,096 to PhRMA Independent Expenditure Committee, $550,000 to Republican State Leadership Committee, and $500,000 to Republican Governors Association.
The filing says PhRMA may require periodic reports or similar documentation depending on the grant’s nature and purpose. For grants not supporting a specific effort or project, it says monitoring may generally be limited to appropriate documentation and confirmation of the recipient organization’s legitimacy. Recipients are responsible for using grants properly and complying with legal requirements.
Leadership & Key People
Leadership team and compensation from IRS filings
The 2024 filing lists Daniel O’Day as chair, Albert Bourla as vice chair, Paul Hudson as treasurer, and Stephen J. Ubl as president and CEO. It also lists Alexander Hardy, Ashley Magargee, Barry Greene, and Bob Lojewski as directors. Anthony Mancini is listed as a director through August 2024, and Brad Bailey as a director as of August 2024.
Pharmaceutical Research and Manufacturers of America is led by Stephen J Ubl, President & CEO on every filing since 2020; 15 of 50 officers listed in 2024 are compensated.
Officers on the 2024 filing
Stephen J Ubl
President & CEO
On filings since 2020
37.5 hrs/week
$3.8M (2020) → $5.9M (2024)
Daniel O' Day
Chair
Treasurer → Vice Chairman, 2023
Vice Chairman → Chair, 2024
On filings since 2020
2 hrs/week
No compensation reported
Alexander Hardy
Director
On filings since 2020
2 hrs/week
No compensation reported
Barry Greene
Director
On filings since 2020
2 hrs/week
No compensation reported
Chris ROUND
Director
On filings since 2020
2 hrs/week
No compensation reported
David Loew
Director
On filings since 2020
2 hrs/week
No compensation reported
David Ricks
Director
Chairman → Director, 2021
On filings since 2020
2 hrs/week
No compensation reported
Emma Walmsley
Director
On filings since 2020
2 hrs/week
No compensation reported
Herve J Hoppenot
Director
On filings since 2020
2 hrs/week
No compensation reported
Jean-Michel Boers
Director
On filings since 2020
2 hrs/week
No compensation reported
Jennifer Taubert
Director
On filings since 2020
2 hrs/week
No compensation reported
Ken Keller
Director
On filings since 2020
2 hrs/week
No compensation reported
Mark Reisenauer
Director
On filings since 2020
2 hrs/week
No compensation reported
Richard F Pops
Director
On filings since 2020
2 hrs/week
No compensation reported
Robert A Bradway
Director
On filings since 2020
2 hrs/week
No compensation reported
Sebastian Guth PhD
Director
On filings since 2020
2 hrs/week
No compensation reported
Robert M Davis
Director
On filings since 2021
2 hrs/week
No compensation reported
Tarek Rabah
Director
On filings since 2022
2 hrs/week
No compensation reported
Bob Lojewski
Director
On filings since 2023
2 hrs/week
No compensation reported
Chris Boerner PhD
Director
On filings since 2023
2 hrs/week
No compensation reported
Chris Viehbacher
Director
On filings since 2023
2 hrs/week
No compensation reported
Douglas L. Langa
Director
On filings since 2023
2 hrs/week
No compensation reported
Jean-Christophe Tellier MD
Director
On filings since 2023
2 hrs/week
No compensation reported
Julie Kim
Director
On filings since 2023
2 hrs/week
No compensation reported
Myrtle Potter
Director
On filings since 2023
2 hrs/week
No compensation reported
Tatsuyki Yasuno
Director
On filings since 2023
2 hrs/week
No compensation reported
Thomas Gibbs
Director
On filings since 2023
2 hrs/week
No compensation reported
Vasant Vas Narasimhan MD
Director
Chairman → Director, 2024
On filings since 2023
2 hrs/week
No compensation reported
Anthony Mancini
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Ashley Magargee
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Brad Bailey
Director
New on the 2024 filing
2 hrs/week
No compensation reported
KEVIN C GORMAN PhD
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Kyle Gano PhD
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Michael Petroutsas
Director
New on the 2024 filing
2 hrs/week
No compensation reported
James C Stansel
General Counsel, Executive Vice President Law & Secretary
General Counsel, Executive Vice President, Law & Secretary → General Counsel, Executive Vice President Law & Secretary, 2021
On filings since 2020
37.5 hrs/week
$1.4M (2020) → $1.8M (2024)
Jennifer Bryant
Executive Vice President, Policy & Research
On filings since 2020
37.5 hrs/week
$1.1M (2020) → $1.9M (2024)
Lori Reilly
COO
Executive Vice President, Advocacy & COO → COO, 2022
On filings since 2020
37.5 hrs/week
$1.7M (2020) → $2.5M (2024)
Robert E. Zirkelbach II
Executive Vice President & Public Affairs
On filings since 2020
37.5 hrs/week
$832K (2020) → $1.2M (2024)
Scott LaGanga
Executive Vice President & State Advocacy
Senior Vice President & State Govt Advocacy → Executive Vice President & State Advocacy, 2023
On filings since 2020
37.5 hrs/week
$1M (2020) → $1.2M (2024)
Shannon C. Monsif
Executive Vice President & Alliance
Senior Vice President & Alliance → Executive Vice President, Advocacy & Strategic All, 2023
Executive Vice President, Advocacy & Strategic All → Executive Vice President & Alliance, 2024
On filings since 2020
37.5 hrs/week
$658K (2020) → $1.1M (2024)
Anne M. Pritchett
Senior Vice President, Policy & Research
On filings since 2022
37.5 hrs/week
$835K (2022) → $2.1M (2024)
Kenneth K McKay IV
Senior Vice President & State Advocacy
Vice President & State Government Advocacy → Senior Vice President & State Advocacy, 2023
On filings since 2022
37.5 hrs/week
$905K (2022) → $936K (2024)
Renuka Iyer
Executive Vice President & Human Resources
Senior Vice President & Human Resources → Executive Vice President & Human Resources, 2023
On filings since 2022
37.5 hrs/week
$175K (2022) → $652K (2024)
Tracey Merchant
CFO, Executive Vice President & Administration
CFO & Executive Vice President of Administration → CFO, Executive Vice President & Administration, 2023
On filings since 2022
37.5 hrs/week
$837K (2022) → $1.3M (2024)
Elizabeth Carpenter
Executive Vice President, Policy & Research
On filings since 2023
37.5 hrs/week
$440K (2023) → $1.1M (2024)
Jay Taylor
Executive Vice President & International
On filings since 2023
37.5 hrs/week
$939K (2023) → $990K (2024)
Michael Woody
Senior Vice President & Federal Advocacy
New on the 2024 filing
37.5 hrs/week
$1.2M (2024)
Steven Tilton
Executive Vice President & Federal Advocacy
New on the 2024 filing
37.5 hrs/week
$920K (2024)
Albert Bourla PhD
Vice Chair
Director → Treasurer, 2023
Treasurer → Vice Chair, 2024
On filings since 2020
2 hrs/week
No compensation reported
Paul Hudson
Treasurer
Director → Treasurer, 2024
On filings since 2020
2 hrs/week
No compensation reported
Former officers (32)
- Former: Anne Esposito (2020–2023) — Senior Vice President & Federal Advocacy
- Former: Paul A. Aines (2020–2023) — CFO, Executive Vice President & Administration
- Former: Richard Moscicki MD (2020–2023) — CMO, Executive Vice President, Science & Reg Advocac
- Former: Robin E. Palchus (2020–2023) — Senior Vice President & Human Resources
- Former: Jean-Jaques Bienaime (2023) — Director
- Former: Debra DeShong (2020–2022) — Executive Vice President & Public Affairs
- Former: Doug Langa (2020–2022) — Director
- Former: Giovanni Caforio (2020–2022) — Director
- Former: Ivan Cheung (2020–2022) — Director
- Former: JC Tellier (2020–2022) — Director
- Former: Jeff Stewart (2020–2022) — Director
- Former: JJ Bienaime (2020–2022) — Director
- Former: Pascal Soriot (2020–2022) — Director
- Former: Paul Perreault (2020–2022) — Director
- Former: Ramona Sequeira (2020–2022) — Chairman
- Former: Tony Loebel (2020–2022) — Director
- Former: Vas Narasimhan (2020–2022) — Chairman-Elect
- Former: Sven Dethlef (2021–2022) — Director
- Former: Bridgett Taylor (2022) — Vice President & Federal Advocacy
- Former: Dan O'Day (2022) — Treasurer
- Former: Deborah Dunsire (2022) — Director
- Former: Scott Lagagna (2022) — Senior Vice President & State Govt Advocacy
- Former: Amy Jackson (2020–2021) — Execdir & Int'l Advocacy
- Former: Kabir Nath (2020–2021) — Director
- Former: Lisa M Joldersma (2020–2021) — Senior Vice President, Policy & Research
- Former: Michel Vounatsos (2020–2021) — Director
- Former: Peter Anastasiou (2020–2021) — Director
- Former: Brian Toohey (2021) — Senior Vice President & Int'l Advocacy
- Former: Brendon O'Grady (2020) — Director
- Former: Kenneth C Frazier (2020) — Director
- Former: Rodger L. Currie (2020) — Executive Vice President & Advocacy
- Former: Scott Olsen (2020) — Senior Vice President & Federal Advocacy
Data from IRS Form 990 filings, 2020–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2024 IRS filing
The highest reported compensation on the 2024 filing was $5.9M, to Stephen J Ubl (President & CEO). 15 officers or directors reported compensation on that filing.
Frequently asked questions about Pharmaceutical Research and Manufacturers of America
How much does Pharmaceutical Research and Manufacturers of America give each year?
Pharmaceutical Research and Manufacturers of America gave $41.4M across 461 grants in 2024, according to its 2024 IRS Form 990. In 2023 it gave $31.3M across 370 grants.
What is Pharmaceutical Research and Manufacturers of America's typical grant size?
Pharmaceutical Research and Manufacturers of America's median grant in 2024 was $20,000, and its average grant was $89,830, across 461 grants on its 2024 IRS Form 990. Organizations receiving their first grant from Pharmaceutical Research and Manufacturers of America that year got $27K on average.
Where does Pharmaceutical Research and Manufacturers of America give grants?
Pharmaceutical Research and Manufacturers of America gives mostly in District of Columbia: 52% of the grant dollars itemized on its 2024 IRS Form 990 went to recipients there. The next largest states were Connecticut (12%) and California (7%). The most frequent recipient cities were Washington, DC (107 grants), Sacramento, CA (21 grants), Tallahassee, FL (14 grants) and Arlington, VA (12 grants).
Does Pharmaceutical Research and Manufacturers of America give general operating support?
Yes: 87% of Pharmaceutical Research and Manufacturers of America's 2024 grants with a stated purpose (401 of 461) were for general or operating support, per its 2024 IRS Form 990. Recurring purposes include "Political Contribution" (60 grants).
Who are Pharmaceutical Research and Manufacturers of America's largest grantees?
Pharmaceutical Research and Manufacturers of America's largest 2024 grantees include We Work for Health ($6,827,095), Yale University ($5,000,000) and American Action Network Inc ($4,000,000), according to its 2024 IRS Form 990. Together they received 38% of its itemized 2024 grant dollars.
How large is Pharmaceutical Research and Manufacturers of America?
Pharmaceutical Research and Manufacturers of America reported $349.0M in total assets on its 2024 IRS Form 990. Its revenue that year was $521.3M.
What does Pharmaceutical Research and Manufacturers of America fund?
PhRMA’s mission is to conduct effective advocacy for public policies that encourage the discovery of important new medicines for patients by biopharmaceutical research companies. See mission & focus areas ↑
How do I apply for a grant from Pharmaceutical Research and Manufacturers of America?
Pharmaceutical Research and Manufacturers of America has no public application process in the sources Grantable reviewed. Check phrma.org for current guidelines, or contact the foundation directly before submitting a request.
What is Pharmaceutical Research and Manufacturers of America's EIN?
Pharmaceutical Research and Manufacturers of America's EIN (Employer Identification Number) is 53-0241211. IRS Form 990 filing data is available on this page for 2020–2024.
Data last updated October 2026. Sourced from IRS Form 990 filings. Research dossier generated October 2026.
Data update history
(6)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS November 12, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS November 12, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS November 14, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS November 15, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS November 14, 2025)
- IRS filings on file for fiscal years 2020–2024
Explore Open Grants
Browse active grant opportunities in Pharmaceutical Research and Manufacturers of America's focus areas in our free grants database
Similar Funders
Funders with grantees in common, and similar funders in District of Columbia
Duke Energy Foundation
Charlotte, NC
The Duke Energy Foundation funds workforce and local economic development, disaster resilience, conservation, clean water, and economic opportunity in North Carolina, South Carolina, Florida, Ohio, Kentucky, and Indiana. Its 2024 grants had a median of $25,000; applications for grants of $20,000 or less are accepted year-round, after applicants discuss proposals with a state representative.
Assets
$1.9M
Grants
41
Total Given
$25.6M
Aetna Foundation Inc
Hartford, CT
Aetna Foundation supported health and wellness, access to health care, and related community needs; its 2021 grants ranged from $5,000 to $1 million, with a median of $40,000, and went to organizations across multiple states, especially in D.C. and Connecticut. Its 2021 filing was marked final, so it appears to have ended or be winding down grantmaking; that filing said there were no restrictions on who could apply and pointed applicants to its website for application materials.
Assets
—
Grants
65
Total Given
$7.2M
Bristol-Myers Squibb Foundation Inc
Princeton, NJ
The Bristol-Myers Squibb Foundation supports health access and stronger health systems, with a focus on adult and pediatric cancers, blood disorders, brain health, and clinical-trial participation in the United States, Brazil, India, and ten Sub-Saharan African countries. In 2024, its median grant was about $134,000, though awards varied widely; it does not state whether it accepts unsolicited requests, and advises prospective applicants to contact the Foundation about its process.
Assets
$83.3M
Grants
144
Total Given
$67.7M
McKesson Foundation Inc
Dallas, TX
The McKesson Foundation funds cancer support and care, healthcare workforce pathways, and emergency response, with grants mainly supporting organizations in the United States and Canada. Its 2025 grants had a median of $100,000, though amounts ranged from $10,000 to about $2.47 million. Its filing says it does not accept unsolicited requests, while its application page describes an online application process with stated submission windows.
Assets
$1.6M
Grants
76
Total Given
$16.6M
NCRC Community Development Fund Inc
Washington, DC
NCRC Community Development Fund supports affordable housing and homeownership, small businesses—especially minority-owned, women-owned, and low-income businesses—and certain nonprofit programs that provide capital or services to underserved communities. Its listed awards range from $5,000 to $50,000, though typical giving is not stated; it serves communities across the U.S., with some programs focused on Illinois. The profile does not state whether it accepts unsolicited requests.
Assets
$55.6M
Grants
2,666
Total Given
$149.3M
Greater Washington Community Foundation
Washington, DC
The Greater Washington Community Foundation supports nonprofits working across areas such as economic opportunity, education, health, arts, and human services, with an emphasis on equity and economic justice. Its 2025 grants had a median of $20,000, and it generally funds organizations serving DC, Montgomery County, Prince George’s County, and specified Northern Virginia communities; it offers scheduled open competitive grant rounds as well as invite-only opportunities.
Assets
$518.3M
Grants
1,417
Total Given
$116.9M
More similar funders
More Funders in District of Columbia
Cite this profile
Grantable. (2026). Pharmaceutical Research and Manufacturers of America funder profile. GrantGraph. Retrieved October 6, 2026, from https://grantable.co/funders/pharmaceutical-research-and-manufacturers-of-america-morg_0539f26200bc4da08c5b14d109fd4d62
BibTeX
@misc{grantable_530241211_2026,
author = {{Grantable}},
title = {{Pharmaceutical Research and Manufacturers of America funder profile}},
howpublished = {GrantGraph},
year = {2026},
url = {https://grantable.co/funders/pharmaceutical-research-and-manufacturers-of-america-morg_0539f26200bc4da08c5b14d109fd4d62},
note = {Accessed 2026-10-06. Data licensed CC BY 4.0}
}The figures on this page are open data under CC BY 4.0: reuse them with credit to Grantable and a link. Download the data.
Figures come from Pharmaceutical Research and Manufacturers of America's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
Pharmaceutical Research and Manufacturers of America down — hundreds of funders to go?